Skip to main content
. Author manuscript; available in PMC: 2018 Mar 30.
Published in final edited form as: Hypertension. 2017 Oct 30;71(1):151–159. doi: 10.1161/HYPERTENSIONAHA.117.10251

Figure 4.

Figure 4

Leg α2-adrenergic mediated vasoconstrictor responses to tyramine. Percentage changes in leg vascular conductance with arterial tyramine infusion with terazosin+placebo (TER+PLA) and with terazosin+probenecid (TER+PROB). n=5. *Significantly different from PLA (P<0.05).